Company intelligence / Profile preview

Akron Bio

Boca Raton, Florida, United Statesakronbiotech.com ↗

Ownership: Private
Employees: ~111
Development stage: Commercial

Overview

Akron Bio does not have its own clinical results as it supplies critical raw materials—such as cGMP plasmid DNA, cytokines, growth factors—to advanced therapy developers from pre-clinical to commercial stages. Its products are used in the manufacture of cell and gene therapies by other companies

Therapeutic areas: Other
Modalities: Cell therapyGene therapyRecombinant proteinPlasmid DNA (Biologic)Cytokine (Biologic)Nuclease (Protein/Enzyme)
Industry: Contract Manufacturing Organization

Partnerships

Charles River Laboratories (collaboration to integrate cGMP materials into cell therapy platform)Multiply Labs (automation of liquid cytokines in cell therapy manufacturing)Vor Bio (development/manufacture of nucleases for engineered HSC/CAR-T programs)

Beyond the preview

Go deeper on Akron Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akron Bio.

Explore the full profile